No Data
Chinese Drug Regulator Accepts Xianju Pharmaceutical's Application to Evaluate Hormonal Medication
Zhejiang Xianju Pharmaceutical (002332.SZ): The consistency evaluation of medroxyprogesterone acetate tablets has been accepted.
Zhejiang Xianju Pharmaceutical (002332.SZ) announced that the company recently received a notice from the National Medical Products Administration regarding acetic acid...
Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Market Cap Dropped CN¥435m Last Week; Individual Investors Who Hold 52% Were Hit as Were Institutions
Xianju Pharmaceutical to Set Up New Subsidiary
Zhejiang Xianju Pharmaceutical (002332.SZ) plans to establish a new subsidiary to undertake part of the Active Pharmaceutical Ingredient segment business.
Zhejiang Xianju Pharmaceutical (002332.SZ) announced that the company aims to improve management efficiency and enhance and optimize the Active Pharmaceutical Ingredient business...
Zhejiang Xianju Pharmaceutical (002332.SZ): The high-end formulation project has entered the equipment installation and debugging stage.
Gelonghui, December 23丨Zhejiang Xianju Pharmaceutical (002332.SZ) stated on the investor interactive platform that the high-end formulation project has entered the equipment installation and debugging stage. The company's goodwill was formed in the consolidated balance sheet after the acquisition of 100% equity of the Italian companies Newchem and Effechem in 2017.
Little Excitement Around Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Earnings As Shares Take 27% Pounding
No Data
